{"id":"https://openalex.org/W4391999643","doi":"https://doi.org/10.1016/j.amjmed.2024.02.005","title":"Comparative Safety and Effectiveness of Reduced Doses of Direct Acting Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation","display_name":"Comparative Safety and Effectiveness of Reduced Doses of Direct Acting Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation","publication_year":2024,"publication_date":"2024-02-21","ids":{"openalex":"https://openalex.org/W4391999643","doi":"https://doi.org/10.1016/j.amjmed.2024.02.005","pmid":"https://pubmed.ncbi.nlm.nih.gov/38387539"},"language":"en","primary_location":{"id":"doi:10.1016/j.amjmed.2024.02.005","doi":"https://doi.org/10.1016/j.amjmed.2024.02.005","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.amjmed.2024.02.005","pdf_url":null,"source":{"id":"https://openalex.org/S186920367","display_name":"The American Journal of Medicine","issn_l":"0002-9343","issn":["0002-9343","1555-7162"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The American Journal of Medicine","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5105003701","display_name":"Flemming Skj\u00f8th","orcid":"https://orcid.org/0000-0003-2975-647X","observed_orcids":["https://orcid.org/0000-0003-2975-647X"]},"institutions":[{"id":"https://openalex.org/I2799976261","display_name":"Aalborg University Hospital","ror":"https://ror.org/02jk5qe80","country_code":"DK","type":"healthcare","lineage":["https://openalex.org/I2799976261"]},{"id":"https://openalex.org/I891191580","display_name":"Aalborg University","ror":"https://ror.org/04m5j1k67","country_code":"DK","type":"education","lineage":["https://openalex.org/I891191580"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"Flemming Skj\u00f8th","raw_affiliation_strings":["Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Faculty of Health, Aalborg University, Aalborg, Denmark; Research Data and Biostatistics, Aalborg University Hospital, Aalborg, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Faculty of Health, Aalborg University, Aalborg, Denmark; Research Data and Biostatistics, Aalborg University Hospital, Aalborg, Denmark","institution_ids":["https://openalex.org/I2799976261","https://openalex.org/I891191580"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078667862","display_name":"Torben Bjerregaard Larsen","orcid":"https://orcid.org/0000-0002-8485-8674","observed_orcids":["https://orcid.org/0000-0002-8485-8674"]},"institutions":[{"id":"https://openalex.org/I2799976261","display_name":"Aalborg University Hospital","ror":"https://ror.org/02jk5qe80","country_code":"DK","type":"healthcare","lineage":["https://openalex.org/I2799976261"]},{"id":"https://openalex.org/I891191580","display_name":"Aalborg University","ror":"https://ror.org/04m5j1k67","country_code":"DK","type":"education","lineage":["https://openalex.org/I891191580"]}],"countries":["DK"],"is_corresponding":true,"raw_author_name":"Torben Bjerregaard Larsen","raw_affiliation_strings":["Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Faculty of Health, Aalborg University, Aalborg, Denmark; Department of Cardiology, Aalborg University Hospital, Aalborg, Denmark. Electronic address: torben.bjerregaard.larsen@rsyd.dk"],"raw_orcid":"https://orcid.org/0000-0002-8485-8674","affiliations":[{"raw_affiliation_string":"Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Faculty of Health, Aalborg University, Aalborg, Denmark; Department of Cardiology, Aalborg University Hospital, Aalborg, Denmark. Electronic address: torben.bjerregaard.larsen@rsyd.dk","institution_ids":["https://openalex.org/I2799976261","https://openalex.org/I891191580"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055377277","display_name":"Alexander Rieem Dun","orcid":"https://orcid.org/0000-0002-8182-5682","observed_orcids":["https://orcid.org/0000-0002-8182-5682"]},"institutions":[{"id":"https://openalex.org/I4210148008","display_name":"Quantify Research (Sweden)","ror":"https://ror.org/05nqb8479","country_code":"SE","type":"company","lineage":["https://openalex.org/I4210148008"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Alexander Rieem Dun","raw_affiliation_strings":["Quantify Research AB, Stockholm, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Quantify Research AB, Stockholm, Sweden","institution_ids":["https://openalex.org/I4210148008"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000748427","display_name":"Mathias Lilja","orcid":"https://orcid.org/0000-0001-7927-3770","observed_orcids":["https://orcid.org/0000-0001-7927-3770"]},"institutions":[{"id":"https://openalex.org/I4210148008","display_name":"Quantify Research (Sweden)","ror":"https://ror.org/05nqb8479","country_code":"SE","type":"company","lineage":["https://openalex.org/I4210148008"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Mathias Lilja","raw_affiliation_strings":["Quantify Research AB, Stockholm, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Quantify Research AB, Stockholm, Sweden","institution_ids":["https://openalex.org/I4210148008"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012601813","display_name":"Iffat Rahman","orcid":"https://orcid.org/0000-0001-6472-7063","observed_orcids":["https://orcid.org/0000-0001-6472-7063"]},"institutions":[{"id":"https://openalex.org/I4210160087","display_name":"SDS Life Science (Sweden)","ror":"https://ror.org/05h9mfy97","country_code":"SE","type":"company","lineage":["https://openalex.org/I4210160087"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Iffat Rahman","raw_affiliation_strings":["SDS Life Science AB, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"SDS Life Science AB, Sweden","institution_ids":["https://openalex.org/I4210160087"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080145115","display_name":"Khaled Abdelgawwad","orcid":"https://orcid.org/0000-0002-3596-6273","observed_orcids":["https://orcid.org/0000-0002-3596-6273"]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Khaled Abdelgawwad","raw_affiliation_strings":["Bayer AG, Berlin, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bayer AG, Berlin, Germany","institution_ids":["https://openalex.org/I67348948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057062433","display_name":"Sigrun Halvorsen","orcid":"https://orcid.org/0000-0001-7561-7644","observed_orcids":["https://orcid.org/0000-0001-7561-7644"]},"institutions":[{"id":"https://openalex.org/I1281400175","display_name":"Oslo University Hospital","ror":"https://ror.org/00j9c2840","country_code":"NO","type":"healthcare","lineage":["https://openalex.org/I1281400175"]},{"id":"https://openalex.org/I184942183","display_name":"University of Oslo","ror":"https://ror.org/01xtthb56","country_code":"NO","type":"education","lineage":["https://openalex.org/I184942183"]}],"countries":["NO"],"is_corresponding":false,"raw_author_name":"Sigrun Halvorsen","raw_affiliation_strings":["Department of Cardiology, Oslo University Hospital Ullev\u00e5l, University of Oslo, Oslo, Norway"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cardiology, Oslo University Hospital Ullev\u00e5l, University of Oslo, Oslo, Norway","institution_ids":["https://openalex.org/I1281400175","https://openalex.org/I184942183"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065282629","display_name":"Craig Ian Coleman","orcid":"https://orcid.org/0000-0003-4868-7158","observed_orcids":["https://orcid.org/0000-0003-4868-7158"]},"institutions":[{"id":"https://openalex.org/I140172145","display_name":"University of Connecticut","ror":"https://ror.org/02der9h97","country_code":"US","type":"education","lineage":["https://openalex.org/I140172145"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Craig Coleman","raw_affiliation_strings":["School of Pharmacy, University of Connecticut, West Suffield, Conn"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Pharmacy, University of Connecticut, West Suffield, Conn","institution_ids":["https://openalex.org/I140172145"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5005894092","display_name":"Marcela Rivera","orcid":"https://orcid.org/0000-0003-4551-6134","observed_orcids":["https://orcid.org/0000-0003-4551-6134"]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Marcela Rivera","raw_affiliation_strings":["Bayer AG, Berlin, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bayer AG, Berlin, Germany","institution_ids":["https://openalex.org/I67348948"]}]}],"institutions":[],"countries_distinct_count":5,"institutions_distinct_count":8,"corresponding_author_ids":["https://openalex.org/A5078667862"],"corresponding_institution_ids":["https://openalex.org/I2799976261","https://openalex.org/I891191580"],"apc_list":{"value":3520,"currency":"USD","value_usd":3520},"apc_paid":null,"fwci":1.3228,"has_fulltext":false,"cited_by_count":5,"citation_normalized_percentile":{"value":0.80930408,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":97},"biblio":{"volume":"137","issue":"6","first_page":"520","last_page":"528.e13"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10065","display_name":"Atrial Fibrillation Management and Outcomes","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10065","display_name":"Atrial Fibrillation Management and Outcomes","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10227","display_name":"Acute Ischemic Stroke Management","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10285","display_name":"Venous Thromboembolism Diagnosis and Management","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2724","display_name":"Internal Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/dabigatran","display_name":"dabigatran","score":0.9110000133514404},{"id":"https://openalex.org/keywords/rivaroxaban","display_name":"rivaroxaban","score":1.0},{"id":"https://openalex.org/keywords/apixaban","display_name":"apixaban","score":1.0},{"id":"https://openalex.org/keywords/warfarin","display_name":"warfarin","score":0.9520000219345093},{"id":"https://openalex.org/keywords/non-valvular-atrial-fibrillation","display_name":"non-valvular atrial fibrillation","score":0.9399999976158142},{"id":"https://openalex.org/keywords/stroke-prevention","display_name":"stroke prevention","score":0.9490000009536743},{"id":"https://openalex.org/keywords/ischemic-stroke","display_name":"ischemic stroke","score":0.9100000262260437},{"id":"https://openalex.org/keywords/systemic-embolism","display_name":"systemic embolism","score":0.9990000128746033},{"id":"https://openalex.org/keywords/intracranial-hemorrhage","display_name":"intracranial hemorrhage","score":0.9940000176429749}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9851433634757996},{"id":"https://openalex.org/C2779161974","wikidata":"https://www.wikidata.org/wiki/Q815819","display_name":"Atrial fibrillation","level":2,"score":0.8843077421188354},{"id":"https://openalex.org/C2780645631","wikidata":"https://www.wikidata.org/wiki/Q671554","display_name":"Stroke (engine)","level":2,"score":0.7089638710021973},{"id":"https://openalex.org/C164705383","wikidata":"https://www.wikidata.org/wiki/Q10379","display_name":"Cardiology","level":1,"score":0.376156210899353},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3321989178657532},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.3222578763961792},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.0},{"id":"https://openalex.org/C78519656","wikidata":"https://www.wikidata.org/wiki/Q101333","display_name":"Mechanical engineering","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000069552","descriptor_name":"Rivaroxaban","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000069552","descriptor_name":"Rivaroxaban","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000069552","descriptor_name":"Rivaroxaban","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000069604","descriptor_name":"Dabigatran","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000069604","descriptor_name":"Dabigatran","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000069604","descriptor_name":"Dabigatran","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000083242","descriptor_name":"Ischemic Stroke","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D000083242","descriptor_name":"Ischemic Stroke","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000925","descriptor_name":"Anticoagulants","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000925","descriptor_name":"Anticoagulants","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000925","descriptor_name":"Anticoagulants","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001281","descriptor_name":"Atrial Fibrillation","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D001281","descriptor_name":"Atrial Fibrillation","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011720","descriptor_name":"Pyrazoles","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D011720","descriptor_name":"Pyrazoles","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D011720","descriptor_name":"Pyrazoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D011728","descriptor_name":"Pyridones","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D011728","descriptor_name":"Pyridones","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D011728","descriptor_name":"Pyridones","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D014859","descriptor_name":"Warfarin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D014859","descriptor_name":"Warfarin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D014859","descriptor_name":"Warfarin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D020521","descriptor_name":"Stroke","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":true},{"descriptor_ui":"D020521","descriptor_name":"Stroke","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true},{"descriptor_ui":"D020521","descriptor_name":"Stroke","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D065427","descriptor_name":"Factor Xa Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D065427","descriptor_name":"Factor Xa Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D065427","descriptor_name":"Factor Xa Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1016/j.amjmed.2024.02.005","doi":"https://doi.org/10.1016/j.amjmed.2024.02.005","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.amjmed.2024.02.005","pdf_url":null,"source":{"id":"https://openalex.org/S186920367","display_name":"The American Journal of Medicine","issn_l":"0002-9343","issn":["0002-9343","1555-7162"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The American Journal of Medicine","raw_type":"journal-article"},{"id":"pmid:38387539","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/38387539","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The American journal of medicine","raw_type":"Journal Article"},{"id":"pmh:oai:pure.atira.dk:publications/c261f53d-560d-4ae3-8a49-f4f922f4de86","doi":null,"is_oa":false,"landing_page_url":"https://www.scopus.com/pages/publications/85189702835","pdf_url":null,"source":{"id":"https://openalex.org/S4306401731","display_name":"VBN Forskningsportal (Aalborg Universitet)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I891191580","host_organization_name":"Aalborg University","host_organization_lineage":["https://openalex.org/I891191580"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Skj\u00f8th, F, Larsen, T B, Dun, A R, Lilja, M, Rahman, I, Abdelgawwad, K, Halvorsen, S, Coleman, C & Rivera, M 2024, 'Comparative safety and effectiveness of reduced doses of direct acting oral anticoagulants for stroke prevention in atrial fibrillation', The American Journal of Medicine, vol. 137, no. 6, pp. 520-528.e13. https://doi.org/10.1016/j.amjmed.2024.02.005","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":20,"referenced_works":["https://openalex.org/W1973617793","https://openalex.org/W2007116565","https://openalex.org/W2035305268","https://openalex.org/W2036193982","https://openalex.org/W2048470090","https://openalex.org/W2125336533","https://openalex.org/W2152623033","https://openalex.org/W2587045166","https://openalex.org/W3000776376","https://openalex.org/W3004050106","https://openalex.org/W3010652504","https://openalex.org/W3082188176","https://openalex.org/W3159673032","https://openalex.org/W3160362607","https://openalex.org/W3179562740","https://openalex.org/W4312067564","https://openalex.org/W4327965330","https://openalex.org/W4361266978","https://openalex.org/W4365998014","https://openalex.org/W4378952295"],"related_works":["https://openalex.org/W4385760067","https://openalex.org/W3113439035","https://openalex.org/W2769275060","https://openalex.org/W2948648533","https://openalex.org/W4206616958","https://openalex.org/W7222798665","https://openalex.org/W4224311040","https://openalex.org/W2983944525","https://openalex.org/W4403003791","https://openalex.org/W2995113239"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":2}],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2024-02-22T00:00:00"}